who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此为英文文档_第1页
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此为英文文档_第2页
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此为英文文档_第3页
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此为英文文档_第4页
who -COVID-19 infection prevention and control living guideline - mask use in community settings,22 December 2021-此为英文文档_第5页
已阅读5页,还剩62页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

COVID-19

InfectionPreventionandControl

Livingguideline

Maskuseincommunitysettings

22December2021

WorldHealth

•Organization

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

2of38

Sections

1.

ExecutiveSummary 3

1.1

Abbreviations 3

1.2

Definitions 4

2.

Methodology 5

3.

Advice,statementsandrecommendations 7

3.1

Generalmaskadvice 7

3.2

Maskuseincommunitysettings 7

3.2.1

Maskuseduringphysicalactivity 15

3.2.2

Typeofmaskusedbythegeneralpublic 16

3.3

Maskusebychildren 22

4.

Acknowledgements 29

References 31

WHOcontinuestomonitorthesituationcloselyforanychangesthatmayaffectthislivingguideline.Shouldanyfactorschange,WHOwillissueafurtherupdate.Otherwise,thislivingguidelinewillexpire2yearsafterthedateofpublication.

©WorldHealthOrganization2021.Somerightsreserved.Thisworkisavailableunderthe

CCBY-NC-SA3.0IGOlicence

.WHOreferencenumber:WHO/2019-nCoV/IPC_masks/2021.1

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

3of38

1.ExecutiveSummary

InfoBox

Version1.0InfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuideline

ThisfirsteditionoftheInfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuidelineprovidesthemostuptodatetechnicalguidanceonmaskuseincommunitysettingsinthecontextofCOVID-19.ThislivingguidelineincorporatestheGradingofRecommendations,Assessment,DevelopmentandEvaluations(GRADE)processes(seeMethodologysection)withexisting(previouslypublished)technicalguidanceinMAGICapptoallowuserstoeasilynavigateinfectionpreventionandcontrol(IPC)guidelinesinthedynamicsituationofCOVID-19.Thiseditiontakesintoconsiderationtheevolvingepidemiologicalsituation,includingtheemergenceoftheVoCOmicron.FurtherinformationonOmicronVoCcanbefoundinthefollowingtechnicaldocumentEnhancingReadinessforOmicron(B.1.1.529):TechnicalBriefandPriorityActionsfortheMemberStates,issuedbyWHOon17December2021[1].

Thisdocumentisalivingguideline,whereupdatedornewstatementswillbeaddedasnewevidenceemergesthatwillbereviewedthroughtheGRADEprocess.Thus,theguidelineiswritten,disseminated,andupdatedinMAGICapp.Itsuser-friendlyformatandstructureallowforeasynavigationwhileaccommodatingforthedynamicnatureoftheCOVID-19publichealthemergencyandassociatedevidenceandrecommendations.MAGICAppallowshighlightingofnewandupdatedstatementswhilekeepingexistingstatementsandsupportingevidencewithintheguideline.Thestatementsaremarkedwithdifferentlabelsandcolourcodingtoreflectthedifferentconsolidationapproachesofexistingguidance,updates,andnewstatements.

Inthisedition,newinformationincludesupdatedmaskrecommendationsforthegeneralpublic,astatementonpoliciesforappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducesevereacuterespiratorysyndromecoronavirus2(SARS-CoV-2)transmission,astatementonthetypeofmasktobeusedbyhigher-riskindividuals,andimplementationconsiderationsforthetypeandminimumessentialparametersofmasksusedincommunitysettings.

ThepreviouslypublishedtechnicalguidancedocumentsincorporatedinVersion1.0areasfollows:

1.

MaskuseinthecontextofCOVID-19-December2020

;and

2.

AdviceontheuseofmasksforchildreninthecontextofCOVID-19

-August2020;.

TheWorldHealthOrganization(WHO)recommendstheuseofmasksaspartofacomprehensivepackageofpreventionandcontrolmeasurestolimitthespreadofSARS-CoV-2,thevirusthatcausesCOVID-19.Evenwhenusedcorrectly,amaskaloneisinsufficienttoprovideadequateprotectionorsourcecontrol.Otherpublichealthandsocialmeasuresincludetesting,isolation,contacttracing,quarantine,adequateventilationinindoorsettings,aphysicaldistancingofatleast1metre,handhygiene,andrespiratoryetiquette.Together,thesemeasuresarecriticaltopreventhuman-to-humantransmissionofSARS-CoV-2.Thisdocumentguidesdecision-makers,publichealthandIPCprofessionals,childhealthprofessionalsandnon-medicalmaskmanufacturers.

1.1Abbreviations

aOR

adjustedoddsratio

COVID-19

coronavirusdisease2019

CI

ConfidenceInterval

EtD

EvidencetoDecision

GDG

GuidelineDevelopmentGroup

GRADE

GradingofRecommendations,Assessment,DevelopmentandEvaluations

ILI

Influenza-likeillness

IPA

InternationalPaediatricAssociation

IPC

infectionpreventionandcontrol

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

4of38

NIOSH

NationalInstituteforOccupationalSafetyandHealth

OR

oddsratio

PPE

personalprotectiveequipment

SARS-CoV

severeacuterespiratorysyndromecoronavirus

SARS-CoV-2

severeacuterespiratorysyndromecoronavirus2

UNICEF

UnitedNationsChildren'sFund

UK

UnitedKingdom

USA

UnitedStatesofAmerica

WHO

WorldHealthOrganization

VoC

VariantofConcern

1.2Definitions

Definitions

Healthworkersareallpeopleprimarilyengagedinactionswiththeprimaryintentofenhancinghealth.Examplesarenursingandmidwiferyprofessionals,doctors,cleaners,otherstaffwhoworkinhealthfacilities,socialworkersandcommunityhealthworkers.

Medicalmasksaredefinedassurgicalorproceduremasksthatareflatorpleated,andtheyareaffixedtotheheadwithstrapsaroundtheears,head,orboth.Theirperformancecharacteristicsaretestedaccordingtoasetofstandardizedtestmethods(ASTMF2100,EN14683,orequivalent)thataimtobalancehighfiltration,adequatebreathabilityand,optionally,fluidpenetrationresistance[5][121].

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

5of38

2.Methodology

Methodologyfordevelopingthestatements

StatementsincludedinthisdocumentarebasedonpublishedWHOguidelines(inparticular,theWHOGuidelinesoninfectionpreventionandcontrolofepidemic-andpandemic-proneacuterespiratoryinfectionsinhealthcare)andongoingevaluationsofallavailablescientificevidencebyWHOCOVID-19IPCGuidanceDevelopmentGroup(GDG)(seeAcknowledgements).Thisevidenceisevaluatedthroughexpeditedsystematicreviewsandexpertconsensus-buildingthroughregularGDGconsultationsfacilitatedbyamethodologist.Whenfurtherclarityorconsensusisnecessary,meetingsarefollowedupbyavotingprocessbytheGDGmembers.Recommendationsarebasedonanassessmentofthebalanceofbenefitstoharmsaswellascertaintyintheseassessments.Thisprocessalsoconsiders,asmuchaspossible,potentialresourceimplications,valuesandpreferences,feasibility,equityandethics.Anexternalreviewpanelofexpertsreviewsdraftguidancedocumentsbeforepublication.

Methodologyfordevelopingthislivingguideline

Asdescribedintheexecutivesummary,giventhedynamicsituationoftheCOVID-19pandemic,thisfirsteditionofthislivingguidelinecombinesexistingguidanceformulatedthroughexpertreviewofevidence,theGRADEevidence-to-decision(EtD)framework,andstandardsfortrustworthyguidelines.ForrecommendationsfollowingtheGRADEEtDframework,aGDGcomprisedofindividualswithbroadexpertisespanningmultiplespecialtiesacrossallWHOregions(seeAcknowledgements)wasconvenedovermultiplemeetingswhereGDGmembersreachedagreement(throughconsensusorvotewithsupermajority)onthestatements.

ManagingConflictsofInterest

AfteranalyzingtheDeclarationofInterestformsandconductingtherequiredinternetsearch,WHOconcludednomemberhadfinancialorcommercialinterestsrelatedtoCOVID-19andmasks.Methodsarealignedwith

WHOHandbookforguidelinedevelopment

.

Readershipcuesforapproachesusedtodevelopstatements

Giventheconsolidationprocess,thestatementsaremarkedwithdifferentlabelsandcolourcodestoreflectthesetwoapproaches.ThegreencheckmarksreflectstatementsthatweredevelopedusingtheGRADEEtDframework.PurplecheckmarksrefertostatementsthathavenotgonethroughtheGRADEEtDframeworkprocessbutareinformedbyevidencereviewandaretheproductofexpertconsensus.Thegreybarreferstoimplementationconsiderationswhichsupportstatementsthroughpracticaladvice,andaretheproductofexpert

consensus.

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

6of38

GRADEEtDFramework

GRADEratesscientificevidencetodevelopevidence-basedguidelines.Eachrecommendationisassignedastrengthofrecommendationandqualityofevidence.

GRADEevidenceprofilescontainanassessmentofthequalityoftheevidenceandasummaryoffindingsforeachcriticaloutcomeandeachkeyquestion.TheGDGusesthesesummariesasthebasisfordiscussionsandformulationofrecommendations.

Goodpracticestatementsandimplementationconsiderations

Goodpracticestatementsindicateactionsthatshouldbeimplemented,inmostcircumstances,whenthecertaintysurroundingtheeffectestimatesishigh,butthesupportiveevidenceisindirect.Benefitsarebasedonmultiplebodiesofindirectevidence,oftenchallengingtoreviewsystematically.Goodpracticestatementsaregenerallyreservedforconsiderationswithwidespreadconsensusandwhentheinterventioniswidelyaccepted.Implementationconsiderationsarecriticalelementsthatfacilitatetheappropriateuseofformalstatements.

Timeline

AnexternallivingsystematicreviewhasbeencommissionedtocontinuouslymonitoremergingevidenceontheuseofmasksinthecontextoftheCOVID-19publichealthemergencyofinternationalconcern.Theemergingevidencewilltriggercontinuousupdatesastheneedisidentified.

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

7of38

3.Advice,statementsandrecommendations

3.1Generalmaskadvice

InfoBox

Maskmanagement

Foranytypeofmask,appropriateuse,storage,cleaningordisposalareessentialtoensurethattheyareaseffectiveaspossibleandtoavoidanyincreasedriskoftransmission.Adherencetocorrectmaskmanagementpracticesvaries,reinforcingtheneedforappropriatemessaging[115].WHOprovidesthefollowingguidanceonthecorrectuseofmasks:

•Washhandsthoroughlybeforeputtingonthemask.

•Inspectthemaskfortearsorholes,anddonotuseadamagedmask.

•Placethemaskcarefully,ensuringitcoversthemouthandnose,adjusttothenosebridgeandtieitsecurelytominimizeanygapsbetweenthefaceandthemask.Ifusingearloops,ensurethesedonotcrossoverasthiswidensthegapbetweenthefaceandthemask.

•Avoidtouchingthemaskwhilewearingit.Ifthemaskisaccidentlytouched,washhandsthoroughly.

•Removethemaskusingtheappropriatetechnique.Donottouchthefrontofthemask;rather,untieitfrombehind.

•Replacethemaskassoonasitbecomesdampwithanew,cleananddrymask.

•Eitherdiscardthemaskorplaceitinacleanplasticresealablebagwhereitiskeptuntilitcanbewashedandcleaned.Donotstorethemaskaroundthearmorwristorpullitdowntorestaroundthechinorneck.

•Washhandsimmediatelyafterdiscardingamask.

•Donotreusesingle-usemasks.

•Discardsingle-usemasksaftereachuseandproperlydisposeofthemimmediatelyuponremoval.

•Donotremovethemasktospeak.

•Donotshareyourmaskwithothers.

•Washfabricmasksinsoapordetergentandpreferablyhotwater(atleast60°Centigrade/140°Fahrenheit)atleastonceaday.Ifitisnotpossibletowashthemasksinhotwater,thenwashthemaskinsoap/detergentandroom-temperaturewater,followedbyboilingthemaskfor1minute.

•Amaskshouldbechangedtoacleanmaskatleastoncedaily.

Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.

Exhalationvalvesonrespiratorsandnon-medicalmasksarediscouragedastheydonotallowforadequatesourcecontrolfromthewearer.Exhalationvalvespermitbypassofthefiltrationlayerswhenthewearerexhales,potentiallyallowingpass-throughofinfectiousparticles.

Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.

3.2Maskuseincommunitysettings

8of38

InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2

Updated

Strongrecommendationfor,Moderatecertaintyevidence

InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,irrespectiveofvaccinationstatusorhistoryofpriorinfection,wearingawell-fittingmask*thatcoversthenoseandmouthisrecommendedforthegeneralpublicwheninteractingwithindividualswhoarenotmembersoftheirhousehold:

•inindoorsettingswhereventilationisknowntobepoororcannotbeassessed,ortheventilationsystemisnotproperlymaintained,regardlessofwhetherphysicaldistancingofatleast1metrecanbemaintained1;

•inindoorsettingsthathaveadequateventilationifphysicaldistancingofatleast1metrecannotbemaintained*;or

•inoutdoorsettingswherephysicaldistancingofatleast1metrecannotbemaintained*.

*Masktypesinclude:

•reusable,non-medicalmasksthatcomplywiththe

ASTMF3502

standardor

CENWorkingAgreement17553

,oranon-medicalmaskmeetingWHOessentialparameters(seepracticalinfoformoreinformation).;

•disposablemedicalmasks,complyingwithmedicalmaskstandardsEN14683TypeI,ASTMF2100Level1,YY/T0969,YY0469(orequivalent)iftheavailabilityofmedicalmasksmeetingminimumperformancecriteriaforhealthworkershasbeenassured**;

•iftheaboveoptionsarenotavailable,othertypesofwell-fittingnon-medicalmasksincludinghomemademultilayeredmasks***areanacceptableoption(accordingtolocalpolicies).

1Physicaldistanceshouldbeincreasedbeyond1metrewheneverfeasible.

Updated22December2021.

PracticalInfo

Forinformationonassessingandimprovingindoorventilation,pleaseseeWHO's

Roveensureg

oadmaptoimprandoodindoor

venconoCOVID-19

tilationinthetextf.

Practicalconsiderationsforpolicy-makers:

Thepotentialadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:

•reducedspreadofpotentiallyinfectiousaerosolsordropletsfromexhaledbreath,includingfrominfectedpeoplebeforetheydevelopsymptoms[15];

•encouragingconcurrenttransmissionpreventionbehaviourssuchaswashinghandsandnottouchingtheeyes,noseandmouth[16][17][18];and

•preventingtransmissionofotherrespiratoryillnessessuchastuberculosisandinfluenzaandreducingtheburdenofthesediseasesduringthepandemic[19].

Thepotentialdisadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:

•headacheand/orbreathingdifficulties,dependingonthetypeofmaskused[12];

•developmentoffacialskinlesions,irritantdermatitisorworseningacnewhenusedfrequentlyforlonghours[13][20];

•difficultywithcommunicatingclearly,especiallyforpersonswhoaredeaforhavepoorhearingoruselipreading[21][22];

•poorcompliancewithmask-wearing,inparticularbyyoungchildren[24][25][26][27];

•wastemanagementissues;impropermaskdisposalleadingtoincreasedlitterinpublicplacesandenvironmentalhazards[28];and

•furtherdisadvantagesfor,ordifficultywearingmasksby,certainmembersofthepopulation,especially:children;

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

9of38

developmentallychallengedpeople;thosewithmentalillnessorcognitiveimpairment;thosewithasthma,chronicrespiratoryorbreathingproblems;thosewhohavehadfacialtraumaorrecentoralmaxillofacialsurgery;andthoselivinginhotandhumidenvironments[12][25].

EvidenceToDecision

Benefitsandharms

Substantialnetbenefitsoftherecommendedalternative

TheutilizationofmasksincommunitysettingsislikelyassociatedwithadecreasedriskofSARS-CoV-2infectionscomparedwithnomask-wearing.SARS-CoV-2B.1.617.2(Delta)varianthasbeenreportedtohaveincreased

transmissibility[29][30][31][33][32];mostGDGmembers,therefore,agreedthat,inthecontextoftheDeltavariant,thebenefitsofmask-wearinginthecommunitysettingoutweighpotentialharms.EcologicalstudieshaveidentifiedanassociationwithdecreasednumberofconfirmedcasesofCOVID-19andpoliciesrequiringtheuseofmasks[34][35][36].Aclusterrandomizedcontrolledtrialevaluatingmaskpromotion(asanindirectpublichealthintervention)foundthatinacountrywithlowmaskuse,maskpromotionincreasedmaskuseanddecreasedsymptomaticSARS-CoV-2seroprevalence[37].Conversely,anotherrandomizedcontrolledtrialfoundnostatisticalsignificanceassociatedwithsurgicalmaskuseandareducedriskofSARS-CoV-2[38].Thestudyprovidedanimpreciseestimateformaskutilizationversenoutilization;however,thestudywasnotdesignedtoevaluatetheeffectivenessofmaskuseforsourcecontrol.

ManyGDGmembersnotethat,eventhoughthecertaintyoftheevidenceismoderate,thereisasubstantialneedforWHOtoproducecohesiveandrobustrecommendations,asthenetbenefitsofmaskusebythegeneralpublicoutweighthepotentialharms.

Moderate

CertaintyoftheEvidence

Balanceofdesirableandundesirableoutcomes.

Preferenceandvalues

Nosubstantialvariabilityexpected

DiscussionswithstakeholdersandIPCGDGmembershaveindicatedageneralpreferencetofavourmaskuseincommunitysettings.ManyGDGmembersnotethat,inthecontextoftheDeltavariantandothervariantsofconcern,maskingisavitalSARS-CoV-2mitigationmeasure.Membersexpressedaneedtodocumentaclearopinionontheuseofmasksincommunitysettings,giventheimpactoflocalandnationalvaluesandpreferencesonIPCpolicies.Giventheavailabilityofmasks,communitymaskingislikelyfeasible.

Resourcesandotherconsiderations

Noimportantissueswiththerecommendedalternative

ManyGDGmembersnotedtheglobalsupplychainformaskmanufacturinghasimprovedandwouldnotposeasevereobstacletocommunitymasking.Thecostofbothmedicalmasksandnon-medical(fabric)masksarerelativelylow,anddonotposeasubstantialbarrierforlow-andmiddle-incomecountries.

Gapsinknowledgeandresearchneeds

Investigationsontheutilizationofmasksinthecommunitysettingareongoing;however,publishedworkhasidentifiedtheneedforcontinuedresearch.Wellconductedobservationalstudiesand/orrandomizedcontrolledtrialsexploringtheuseofmasksversusnomasksinvarioussettings(e.g.indoor,outdoor,ventilationstatus,etc.)wouldfurtherclarifyoutstandinginquiriesconcerningmaskuseincommunitysettings.Inaddition,researchinvestigatingtheuseofmasks(includingtypeofmaskandtransmissionscenarios)inthecontextoftheDeltavariantwouldprovidepowerfulevidenceforfuturerecommendations.However,GDGmembersdiscussedthechallengesassociatedwithobtainingcompellingevidencefromarandomizedcontrolledtrialonbehaviouralinterventions.Furthermore,withtheavailabilityofaSARS-CoV-2inoculation,furtherresearchwillbeneededtoreinforcetheimpactofvaccinationonmaskutilizationincommunitysettings.

WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)

10of38

Justification

GDGmemberswereaskedtoevaluatethestrengthoftheproposedrecommendation(strongrecommendationversusconditionalrecommendation).Basedontheavailableevidence,theGRADEprocessandtheEvidencetoDecisionframework,theIPCGDGagreedonastrongrecommendation.TheopinionoftheGDGwassolidifiedviaanonlinesurvey,inwhich82.1%(23/28)ofGDGmembersvotedforastrongrecommendationand17.9%(5/28)votedforaconditionalrecommendation.

New

Goodpracticestatement

InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,policiesshouldbedeveloped,strengthenedandimplementedtoencourageappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducetransmission(ventilation,physicaldistance,handhygiene,andrespiratoryetiquette)includinginparticular,maskadherencebythegeneralpublic.

Updated22December2021.

Justification

GDGmemberswereinitiallyaskedifWHOshoulddevelopastatementontheimportanceofmask-wearingand/orinterventionstoimproveadherencetomask-wearingguidance;however,manymembersthoughtitwasessentialtoconsiderthe“bundle”ofpublichealthsocialmeasuresthatpertaintothegeneralpublic.Theabovegoodpracticestatementwasdeterminedbyanonlinevote,where27GDGmembersresponded,with55.6%(15)votingforthestatementasmentionedabove,whiletheremaining44.4%(12)votedforslightlydifferentwordingforthegoodpracticestatement.

InalltransmissionscenariosofSARS-CoV-2

InfoBox

Updated

Implementationconsideration

Inareaswithknownorsuspectedsporadictransmission,ornodocumentedtransmission,WHOadvisethatdecision-makersshouldapplyarisk-basedapproachfocusingonthefollowingcriteriawhenconsideringtheuseofmasksforthegeneralpublic:

•purposeofmaskuse;

•riskofexposuretoSARS-CoV-2;

•vulnerabilityofthemaskwearer/population;

•settinginwhichthepopulationlives;

•feasibility;

•typeofmask;

•vaccinationcoverage;and

•circulatingvariantsofconcern.

Updated22December2021.

Justification

GDGmembersnotedtheimportanceofincludingvaccinationcoverageandcirculatingvariantsofconcerntotheimplementation

11of38

considerationsgiventheavailabilityofvaccinationandthecurrentlandscapeofSARS-CoV-2transmission.

Inanytransmissionscenario,personswithanysymptomssuggestiveofCOVID-19shouldwearamedicalmaskandadditionally:

•self-isolateandseekmedicaladviceassoonastheystarttofeelunwellwithpotentialsymptomsofCOVID-19(evenifsymptomsaremild);

•followinstructionsonhowtoputon,takeoffanddisposeofmedicalmasksandwashhandsthoroughly[39];

•followalladditionalmeasures,inparticular,respiratoryhygiene,frequenthandwashingandmaintainingaphysicaldistanceofatleast1metrefromotherpersons[75].

•IfamedicalmaskisnotavailableforindividualswithsuspectedorconfirmedCOVID-19,afabricmaskwithfit,filtrationandbreathabilityassessedtomeetWHO'sessentialparametersfornon-medicalmasksshouldbewornbypatientsasasourcecontrolmeasure,pendingaccesstoamedicalmask.Theuseofanon-medicalmaskcanminimizetheprojectionofrespiratoryparticlesfromtheuser[40][41]

AsymptomaticpersonswhotestpositiveforSARS-CoV-2shouldwearamedicalmaskwhenwithothersforaperiodof10daysaftertestingpositive.

Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.

EvidenceToDecision

CertaintyoftheEvidence

Evidenceontheprotectiveeffectofmaskuseincommunitysettings

Atpresent,thereisonlylimitedandinconsistentscientificevidencetosupporttheeffectivenessofmaskinghealthypeopleinthecommunitytopreventinfectionwithrespiratoryviruses,includingSARS-CoV-2[6].Alargerandomizedcommunity-basedtrialinwhich4862healthyparticipantsweredividedintoagroupwearingmedical/surgicalmasksandacontrolgroupfoundnodifferenceininfectionwithSARS-CoV-2[42].Arecentsystematicreviewfoundninetrials(ofwhicheightwerecluster-randomizedcontrolledtrialsinwhichclustersofpeople,versusindividuals,wererandomized)comparingmedical/surgicalmasksversusnomaskstopreventthespreadofviralrespiratoryillness.Twotrialsinvolvedhealthcareworkersandsevenhadcommunity-basedparticipants.ThereviewconcludedthatwearingamaskmaymakelittleornodifferencetothepreventionofILI(RR:0.99;95%CI:0.82–1.18)orlaboratory-confirmedinfluenza(LCI)(RR:0.91;95%CI:0.66–1.26)[11];thecertaintyoftheevidencewaslowforILI,moderateforLCI.

Bycontrast,asmallretrospectivecohortstudyfromBeijingfoundthatmaskusebyentirefamiliesbeforethefirstfamilymemberdevelopedCOVID-19symptomswas79%effectiveinreducingtransmission(oddsratio(OR):0.21;CI0.06-0.79)[43].Acase-controlstudyfromThailandfoundthatwearingamedicalornon-medicalmaskallthetimeduringcontactwithaCOVID-19patientwasassociatedwitha77%lowerriskofinfection(adjustedoddsratio(aOR)0.23;95%CI0.09–0.60)[44].SeveralsmallobservationalstudieswithepidemiologicaldatahavereportedanassociationbetweenmaskusebyaninfectedpersonandthepreventionofonwardstransmissionofSARS-CoV-2infectioninpublicsettings[2][45][46][47].

Anumberofstudies,somepeer-reviewedbutmostpublishedaspre-prints,reportedadeclineinthenumberofCOVID-19casesassociatedwithfacemaskusebythepublic,usingcountry-orregion-level

data.[48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69].Onestudyreportedanassociationbetweencommunitymask-wearingpolicyadoptionandincreasedmovement(lesstimeathome,increasedvisitstocommercial

12of38

locations)[23].Thesestudiesdifferedinsetting,datasourcesandstatisticalmethods,andhaveimportantlimitationstoconsider[70],notablythelackofinformationaboutactualexposureriskamongindividuals,adherencetomask-wearingandtheenforcementofotherpreventivemeasures[71][72].

Studiesofinfluenza,ILIandhumancor

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论